Gout Flares After Stopping Anti‐Inflammatory Prophylaxis: A Rapid Literature Review and Meta‐Analysis

医学 痛风 荟萃分析 安慰剂 中止 内科学 临床试验 随机对照试验 替代医学 病理
作者
Lisa K. Stamp,CHRISTOPHER M. A. FRAMPTON,Jeff A. Newcomb,James R. O’Dell,Ted R. Mikuls,Nicola Dalbeth
出处
期刊:Arthritis Care and Research [Wiley]
卷期号:77 (6): 720-726 被引量:11
标识
DOI:10.1002/acr.25486
摘要

OBJECTIVE: The aim of this research was to determine how common gout flares are after ceasing anti-inflammatory prophylaxis. METHODS: A rapid literature review and meta-analysis were undertaken. PubMed was searched from inception to February 2024. Eligibility criteria included any clinical trial of people with gout with at least one arm starting or intensifying urate-lowering therapy (ULT) with coprescription of anti-inflammatory prophylaxis and that had the percentage of participants experiencing one or more gout flares reported during and after the period of prophylaxis. Random effects meta-analyses were used to generate pooled estimates of the percentage of participants experiencing one or more flares in each period. RESULTS: Six trials were included, together with aggregated, unpublished data from the VA STOP Gout trial (2,972 participants). Pooled random effects estimates of the percentage of participants having one or more gout flares were 14.7% (95% confidence interval [CI] 11.3-18.5%) during prophylaxis, 29.7% (95% CI 22.9-37.0%) in the three-month period after ceasing prophylaxis, and 12.2% (95% CI 6.8-19.0%) during the last study period. The mean difference in the percentage of participants having one or more gout flare while taking prophylaxis and immediately after ceasing prophylaxis was -14.8.0% (95% CI -21.2% to -8.5%; P < 0.0001). The mean difference from the period immediately following prophylaxis discontinuation compared to the last study period was 16.0% (P < 0.001). Sensitivity analyses indicated no material effects of prophylaxis duration, trial duration, ULT class, or placebo arms. CONCLUSION: Gout flares are common after stopping anti-inflammatory prophylaxis but return to levels seen during prophylaxis. Patients should be cautioned about the risk of gout flares and have a plan for effective gout flare management in the three months after stopping anti-inflammatory prophylaxis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
完美世界的应助被TT采纳,获得10
刚刚
1秒前
1秒前
fiveaa完成签到,获得积分10
1秒前
YI发布了新的文献求助10
1秒前
小尤同学发布了新的文献求助10
1秒前
龙傲天完成签到,获得积分10
2秒前
Tina发布了新的文献求助10
2秒前
2秒前
sun发布了新的文献求助10
2秒前
阿威想躺平完成签到 ,获得积分10
2秒前
2秒前
wyjz1314完成签到 ,获得积分10
2秒前
Function完成签到,获得积分10
2秒前
3秒前
Orange的应助被哦吼吼吼吼采纳,获得30
3秒前
xxx完成签到 ,获得积分10
3秒前
RR发布了新的文献求助20
3秒前
4秒前
1609855535完成签到,获得积分10
4秒前
爱睡觉的噜噜完成签到,获得积分10
4秒前
77完成签到,获得积分10
4秒前
白菜芯发布了新的文献求助10
4秒前
4秒前
清秀的战斗机完成签到 ,获得积分10
4秒前
4秒前
4秒前
Jasper的应助被zhangmingyang采纳,获得10
4秒前
5秒前
新新完成签到,获得积分10
5秒前
ding的应助被YI采纳,获得10
5秒前
yfy发布了新的文献求助10
5秒前
5秒前
脸又圆了发布了新的文献求助10
6秒前
OK绷完成签到,获得积分20
6秒前
高大汉堡完成签到,获得积分10
6秒前
隐形的烧鸭完成签到,获得积分10
6秒前
西蜀海棠完成签到 ,获得积分10
6秒前
6秒前
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175943
求助须知:如何正确求助?哪些是违规求助? 9567501
关于积分的说明 21793186
捐赠科研通 7770490
什么是DOI,文献DOI怎么找? 3431935
关于科研通互助平台的介绍 2556294
邀请新用户注册赠送积分活动 2477485